Loading...

IRadimed Corporation

IRMD•NASDAQ
Healthcare
Medical - Devices
$71.50
$-1.16(-1.60%)

IRadimed Corporation (IRMD) Stock Overview

Explore IRadimed Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.6/100

Key Financials

Market Cap909.5M
P/E Ratio44.53
EPS (TTM)$1.61
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Week$64.83
1 Month$62.59
3 Months$60.94
1 Year Target$62.27

IRMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IRadimed Corporation (IRMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 44.53 and a market capitalization of 909.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.21%
5-Day Change
-0.12%
1-Month Change
-3.62%
3-Month Change
-11.47%
6-Month Change
2.06%
Year-to-Date (YTD) Change
-8.81%
1-Year Change
21.72%
3-Year Change
20.66%
5-Year Change
154.70%
All-Time (Max) Change
406.06%

Contact Information

https://www.iradimed.com
407 677 8022
1025 Willa Springs Drive, Winter Springs, FL, 32708

Company Facts

160 Employees
IPO DateJul 16, 2014
CountryUS
Actively Trading

Frequently Asked Questions

;